Inflammation  >>  cyclosporine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT01079988: Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

Completed
4
41
Canada
Cyclosporins, Retinoids, Systemic corticosteroids, Methotrexate, Systemic corticosteroids/methotrexate
Merck KGaA, Darmstadt, Germany
Psoriasis
12/04
04/05
NCT00821587: Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation

Completed
4
39
NA
Cyclosporine, Gengraf, Tacrolimus, Prograf
University of Florida, Novartis Pharmaceuticals
Hepatitis C
05/08
05/08
CONCERVIC, NCT01469884: Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

Completed
4
30
RoW
Everolimus, Cyclosporine, Tacrolimus
Irmandade Santa Casa de Misericórdia de Porto Alegre, Novartis
Renal Allograft, Hepatitis C
04/15
04/15
NCT03150134: Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Unknown status
4
100
RoW
Cyclosporine, immunosuppressive agents, routine reduction of immunosuppressive drugs(cyclosporine), cyclosporine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Acute Myeloid Leukemia, Disorder Related to Bone Marrow Transplantation
01/20
01/21
NCT04515329: Tear Film Markers in Dry Eye Syndrome

Withdrawn
4
50
US
Cyclosporine, Cequa, Artificial tear, Preservative-free artificial tears
Vishal Jhanji, Sun Pharmaceutical Industries Limited
Dry Eye
12/23
12/23

Download Options